Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · IEX Real-Time Price · USD
0.750
0.00 (0.00%)
At close: Jul 19, 2024, 4:00 PM
0.710
-0.040 (-5.33%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Quince Therapeutics Market Cap
Quince Therapeutics has a market cap or net worth of $32.41 million as of July 22, 2024. Its market cap has decreased by -39.19% in one year.
Market Cap
32.41M
Enterprise Value
-21.41M
1-Year Change
-39.19%
Ranking
Category
Stock Price
$0.75
Market Cap Chart
Since May 9, 2019, Quince Therapeutics's market cap has decreased from $855.60M to $32.41M, a decrease of -96.21%. That is a compound annual growth rate of -46.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 32.40M | -28.00% |
| Dec 29, 2023 | 45.00M | 95.65% |
| Dec 30, 2022 | 23.00M | -93.90% |
| Dec 31, 2021 | 377.10M | -53.98% |
| Dec 31, 2020 | 819.50M | -45.64% |
| Dec 31, 2019 | 1.51B | 76.19% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Holdco Nuvo Group D.G | 33.43M |
| Orgenesis | 33.05M |
| Immuneering | 32.92M |
| ReWalk Robotics | 32.69M |
| ImmuCell | 32.50M |
| IRIDEX | 32.34M |
| Cutera | 31.96M |
| Longeveron | 31.59M |